Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Glad they went in to better hands.
I agree. It would have nice to have it done in time for elections, but I guess the silver lining is that it would have only attracted flippers. Right now, the majority of people who are buying are holding strong which is better for the stock. As I've said before, it's not a fast mover (which makes it unappealing for flippers), but it's steady in a stair step kind of way. The uptrend is undeniable, and the best part is we are not even close to fair valuation!
Exactly. Who cares if it happens before or after elections. This is not a name/ticker change play. This is a real company that is positioning itself in the right place at the right time to take advantage of the growing MJ sector. With more states legalizing MJ, and that's something that is going to be ongoing for awhile, UBQU will grow revs and the sp will reflect that for a long time to come!
It will be a nice Christmas present for those of us who get it.
This stuff is too easy sometimes.
Shhhhh... be vewwy vewwy quiet. I'm hunting wabbits.
It's gonna get there (and beyond) one way or another... it's not a matter of if, but when.
Welcome, and I couldn't agree more!
Yes, all the while causing downward movement in the stock price in order to maximize profits. lol
Exactly! Churning is a boring, but necessary, part of upward momentum. I should learn to go to the beach when stocks are breathing. lol. It would let me recharge for the next jaw-dropping move. Need all the strength I can get for all that jumping up and down, clapping, and cheering I'll be doing on the next leg. lol
ROFL!!! Too funny!
I wonder who thinks to themselves, "Let me sell my shares at a 25% discount for no reason at all" lol
LOL... That's funny because it's true!
The chart needed to breathe and reset. Holding up extremely well considering everything was down today.
The company stated there will be no further dilution. They obtained a non interest bearing, nonconvertible loan from Medmar for the psoriasis cream which will be coming out soon. Medmar has agreed to use proceeds from sales for loan repayment.
You think they made an offer without knowing what they were buying? That's not how big pharma operates. lol
Yeah, quote from the article:
"OWC recently reported a study by the Sheba Medical Center that showed a 60% reduction of malignant multiple myeloma cells within 24 hours of treatment using the cannabis plant’s active ingredients."
Every big pharma company in the world would want to get their hands on a treatment that effective!
Yes, and Teva offered to buy their patents last year. They are obviously worth more than what TEVA offered. Any new offer will have to be better.
http://www.jewishpress.com/news/breaking-news/teva-pharmaceuticals-thinks-its-high-time-for-medical-marijuana/2015/07/21/
Another one:
Just remember OWCP has a low float and there is NO TOXIC DEBT AND NO DILUTION! Refer to all DD! Read the OWCP filings the notes were paid in full! OWCP is a perfect low float MJ Cannabis play that has all the DD that shows they should be moving tot the big boards just ahead and be huge in the bio pharmaceutical stocks world! Thee last of the convertible debt was solid Sept9th through Oct. 3 and look how much OWCP has ran since the convertible debt was paid off. NO MORE CONVERTABLE DEBT AND NO TOIXIC DEBT MEANS NO DILUTION!
OWCP 8K:
Item 8.01 Other Events.
The Registrant is reporting in this Form 8-K that on October 24, 2016, the Registrant filed a Form 10-Q/A correcting the date at which it had 81,460,875 shares of common stock outstanding from October 18, 2016 to June 30, 2016. The incorrect date included in the October 18, 2016 Form 10-Q/A was the result of an inadvertent error by the Registrant's EDGAR Agent. Because of the national holiday in Israel on October 18 and October 19, 2016, the Registrant filed the corrected form 10-Q/A and this 8-K on the first business day after the national holiday. At October 24, 2016, the Registrant had 135,305,475 shares outstanding as a result of the conversion of all outstanding convertible notes during the period from September 9 to October 3, 2016.
http://ih.advfn.com/p.php?pid=nmona&article=72732362
A great post by cj:
Very important! OWCP should be a $1.50 plus stock just ahead IMO. OWCP an Israeli-based developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced it signed an agreement for $300,000 with Medmar LLC ("Medmar").
According to the terms of the agreement:
The funds will be allocated to complete the development of the Company's proprietary psoriasis cream;
Medmar will have exclusive right to manufacture, produce, publicize, promote and market OWC's Licensed Products in any state in the U.S;
The loan is non-interest bearing and will be repaid from royalties generated by the sale of OWC licensed products.
More details:
Medmar has agreed to loan OCW Ltd a total of $300,000 (the “Loan”) on a non-interest bearing basis, with no conversion rights. Medmar will fund the Loan in six equal installments of $50,000 each, as follows: (i) 1st installment was released to OWC Ltd on September 22, 2016; (ii) 2nd installment on October 1, 2016; (iii) 3rd installment on November 1, 2016; (iv) 4th installment on December 1, 2016; (v) 5th installment on January 1, 2017; and (vi) 6th installment on February 1, 2017. The Loan, as noted above, bears no interest, is not convertible, is due in 36 months from the Effective Date, and repayment shall be made only by the set off of royalties payable by Medmar to OWC Ltd.
PR:https://finance.yahoo.com/news/owc-pharmaceutical-research-corp-signs-120000921.html
8k: http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11614519 .
OWCP Looks to Bring Pharma-Grade Cannabis Therapeutics to Market!!!
There are many different companies active in the medical marijuana industry, but few of them are conducting clinical research trials in accord with the Helsinki Committee Institutional Review Board protocols. Most investors are familiar with GW Pharmaceuticals plc (NASDAQ: GWPH) and its Sativex® cannabinoid medicine for the treatment of multiple sclerosis symptoms and cancer pain indications, but OWC Pharmaceutical Research Corp. (OTCQB: OWCP) is a lesser known company operating in the burgeoning industry.
Based in Israel, an international tech and biotech hub, and the epicenter of medical cannabis research, the OWCP is conducting clinical trials of cannabis-based treatments for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder and migraines. The team is also working on several proprietary drug delivery mechanisms designed to provide consistent and reliable cannabinoid doses to patients more efficiently than smoking or consuming marijuana edibles.
Full Article below Please watch the interview: http://www.baystreet.ca/viewarticle.aspx?id=437873 .
99% of all CANNABIS RESEARCH IS BEING DONE IN ISREAL, OWCP IS AT THE EPICENTER OF THIS WORK
OWCP named one of top 20 Cannabis Stocks by Cannabis Investor Magazine!!!
Cannabis Investor Magazine June Top 20 Cannabis Stocks
OWCP made the list huge recognition we are sitting on a goldmine.
Really? Show me another profitable MJ stock trading at less than .03. Since there are so many, it shouldn't be difficult to pull up just one. I'll be waiting.
Do they have earnings to back them up?
And tens and tens of millions bought in the .002 to .004 range in the past three sessions. What's your point?
Based on the chart in your signature, I take it your bids haven't filled?
Read the PR again. They expect each clinic to yield $2.5 million revs or $25 million for the 10 clinics.
Here's an article to an OWCP interview:
http://hightimes.com/medicinal/high-times-interview-from-israel-with-dr-yehuda-baruch/
Elections, ticker change, and increasing sales! But, dude, what is up with your name? lol
I see. Nothing wrong with profit-taking, but when you know a stock is completely undervalued based on fundamentals, I'd rather hold for the big money.
Impossible to flip enough shares on this volume to make any decent money. There are much better stocks to flip. Anyone bragging about flipping UBQU doesn't know how to trade... sorry... lol.
.03 to .031? Seriously? If you flip 100k shares at those prices, you've made a hundred bucks. That's called a Walmart job, not trading. ROFL!
Repost: OWCP Best OWCP DD post IMO, please read the link below it has everything I only posted atrial below:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=125723556 on growth and value of OWCP
OWCP Looks to Bring Pharma-Grade Cannabis Therapeutics to Market!!!
OWCP is conducting clinical trials of cannabis-based treatments for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder and migraines.
Big Money to be made here.
Multiple myeloma - orphan status designation possible - $7.3 billion in 2014 to $8.9 billion by 2021
Psoriasis - marketing of a cannabinoid-based topical cream - $6.6 billion in 2014 to over $13.3 billion by 2024
Fibromyalgia - orphan status designation possible - $1.8 billion in 2013 to $1.9 billion by 2023
Post-Traumatic Stress Disorder ( PTSD ) - annual cost to society of anxiety disorders is estimated to be significantly over $42.3 billion
Source links below.
Multiple myeloma - In preliminary studies, OWCP's in-vitro testing indicated that specific formulations of CBD and THC decreased survival of multiple myeloma cells in a concentration-dependent manner, and resulted in 100% malignant cell death in 60% of cases. This formulation will now be tested in a pre-clinical, IRB approved protocol on mice in an effort to duplicate those results.
Psoriasis - OWCP completed development of a Topical Cream infused with Cannabis oil extracts to be studied for Psoriasis skin disease. OWCP has started the final phase for testing the efficacy of its own developed topical crème compound for the treatment of psoriasis and related skin conditions.
Post-Traumatic Stress Disorder ( PTSD ) - An estimated 8% of Americans - 24.4 million people - have PTSD at any given time. That is equal to the total population of Texas. At present,OWCP is negotiating with two other Israeli leading medical centers for the collaboration in the research of migraine and PTSD (post-traumatic stress disorder). The Company expects these agreements to be finalized during the fourth quarter of 2015.
Haha... very funny!
This article states that sales ratios, rather than PE, are used for valuation of MJ stocks. They trade at an average of 35x sales, which sounds high, but it's because it's an infant in an extremely high growth sector.
http://www.cannabisfn.com/cannabis-valuations-are-lofty-now-but-could-be-cheap-long-term/
No, he means .05... on the way to .10, .25. .50, etc. We are nowhere near fair value.
That would be nice. This one is still very early considering what's coming down the pipeline.
Unfortunate for them but fortunate for us. Getting weak hands out only makes us stronger.